Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
* Aceragen Inc ACGN.OQ ACGN.O is expected to report
results on
August 7 (estimated).
*
* Refinitiv's mean analyst estimate for Aceragen Inc is for
a
loss of $1.20 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aceragen
Inc is
$17, above its last closing price of $0.79.
This summary was machine generated August 4 at 12:42 GMT. All
figures in US dollars unless otherwise stated
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary